Teradyne reported that semiconductor test cell bookings rose 32% year-over-year in Q3 2025, driven by increased orders from leading chipmakers scaling production of AI accelerators. Robotics segment revenue climbed 28% over the same period, as consumer and logistics customers expanded automation deployments. Management highlighted that combined test and robotics orders backlog grew to $1.8 billion, a 45% increase compared with the prior-year quarter.

In October 2025, Teradyne unveiled its Titan HP system, designed to test high-performance AI processors at speeds up to 400 gigabits per second per channel. The company noted initial shipments to three major hyperscale cloud providers with expected ramp-up in production through mid-2026. Titan HP’s modular architecture allows customers to scale channel counts from 192 to 768, reducing test cycle times by up to 40% compared with legacy platforms.

Among 12 Wall Street analysts covering Teradyne, 9 maintain a Buy rating and 3 rate the shares as Hold. Consensus revenue estimates for fiscal 2026 call for 22% growth, while earnings per share are forecast to rise 30%. Zacks Investment Research assigns Teradyne a Rank #2 (Buy), citing a track record of delivering returns exceeding the S&P 500 by an average of 23.8% annually since 1988.